OPTOSOLVE RESEARCH & DEVELOPMENT LIMITED
Company number 08975155 · Active · Redditch B98 7ST
OPTOSOLVE RESEARCH & DEVELOPMENT LIMITED is an active private limited company (company number 08975155) incorporated on 3 April 2014, registered in Redditch. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 30 April 2025, showing net assets of −£245k and cash of £1,327, with 0 employees on average. Net assets fell 9% on the prior period (−£225k).
By net assets it sits in the bottom quarter of 2,418 comparable companies in the UK (median £1,000, upper quartile £92k).
Key dates
- Incorporated
- 3 April 2014
- Next accounts due
- 30 January 2027 — in 100 days
- Confirmation statement due
- 17 April 2027 — in 177 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- Micro (Companies Act thresholds)
Financials — 2 periods on record, latest ending 30 April 2025
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 April 2025 | −£245k | £1,327 | −£63k | — | — | — | 0 |
| 30 April 2024 | −£225k | £1,009 | −£43k | — | — | — | 0 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Firmoscan score: 43/100 (grade D)
- -15 Negative net assets — Net assets £-245,456 at 2025-04-30
- +8 Established — Incorporated 2014-04-03 (13 years)
A transparent, rules-based score from filed data only: every point lists its evidence. It is not a credit rating or advice.
Ownership and control
- Prof. Anant Sharma — owns 25–50% of shares · since 26 April 2025
- Mr Andrew Nigel Knight — owns 50–75% of shares · since 26 April 2025
- (persons with significant control statement) — · since 4 April 2017 · ceased 26 April 2025
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents.
Similar companies in Birmingham
Same activity (research and experimental development on biotechnology), closest in incorporation date.
- CELGENE RECEPTOS LIMITED — Birmingham, inc. Jan 2014
- VIROSENSE HEALTH LTD — Birmingham, inc. Sept 2014
- ZIMMER AND PEACOCK LIMITED — Smethwick, inc. Oct 2014
- FOOD INNOVATION TECHNOLOGIES LIMITED — Birmingham, inc. Mar 2013
- NONACUS LIMITED — Birmingham, inc. May 2015
- TYG ONCOLOGY LTD. — Birmingham, inc. Jan 2013
All companies incorporated on 3 April 2014 · in Apr 2014.
Reminders for OPTOSOLVE RESEARCH & DEVELOPMENT LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.